Benjamin Kornitzer - 15 Dec 2022 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Role: Chief Med. & Quality Officer
Signature: /s/ Timothy Bensley, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 15 Dec 2022
Net transactions value: +$28,229
Form type: 4/A - Amendment
Filing time: 09 Jan 2023, 16:13:16 UTC
Date Of Original Report: 19 Dec 2022
Previous filing: 07 Dec 2022
Next filing: 09 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Options Exercise	$20,254	+4,511	+43%	$4.49^*	14,937	16 Dec 2022	Direct	F1
transaction	AGL	Common Stock	Options Exercise	$7,974	+887	+5.9%	$8.99	15,824	16 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-4,511	-1.6%	$0.000000	275,000	16 Dec 2022	Common Stock	4,511	$4.49	Direct	F2
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-887	-0.35%	$0.000000	249,113	16 Dec 2022	Common Stock	887	$8.99	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted stock units.
F2	These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024.
F3	These options were granted on January 31, 2020 and vested on September 14, 2021.

Remarks:

This Form 4 Amendment corrects the tranche of 887 vested options exercised by the Reporting Filer as reported on the Form 4 filed on December 19, 2022.